SSRI use and clinical outcomes in epithelial ovarian cancer

Selective serotonin reuptake inhibitor (SSRI) use is common among ovarian cancer patients. We examined the effect of SSRIs on survival and progression in ovarian cancer patients and effects of 5-HT on ovarian cancer cell (OCC) proliferation. Ovarian cancer patients from a 6-site study between 1994 a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Christensen, Desiré K., Armaiz-Pena, Guillermo N., Ramirez, Edgardo, Matsuo, Koji, Zimmerman, Bridget, Zand, Behrouz, Shinn, Eileen, Goodheart, Michael J., Bender, David, Thaker, Premal H., Ahmed, Amina, Penedo, Frank J., DeGeest, Koen, Mendez, Luis, Domann, Frederick, Sood, Anil K., Lutgendorf, Susan K.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5078084/
https://ncbi.nlm.nih.gov/pubmed/27121207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8891
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados